APOE and metabolic dysfunction-associated steatohepatitis: In the current study, we used APOE*3-Leiden mice to demonstrate that atorvastatin, one of the most-often prescribed statins in clinical practice [27], protects against development of diet-induced NASH, mainly by reducing hepatic inflammation and fibrosis.